Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Pertussis Infection in Adolescents and Adults With Prolonged Cough [NA]
Clinical trial update on pertussis infection in adolescents and adults with prolonged cough; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a live intranasal Bordetella pertussis vaccine (GamLPV) investigating protection against whooping cough.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Infanrix-IPV/Hib given in a three-dose schedule with a booster in healthy infants in Ru…
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) [Phase 3]
Phase 3 trial update on long-term persistence of hepatitis B and pertussis antibody responses in healthy 4–5 year-old children previously va…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 immunogenicity and safety study of Infanrix Hexa in healthy infants, including those born to mothers vaccinated during pregnancy or …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Pertussis and Meningitis C Concomitant Vaccination in Adolescents [Phase 4]
Phase 4 trial update on concomitant vaccination for pertussis and meningitis C in adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia [Phase 4]
Phase 4 trial update evaluating the immunogenicity of a single Boostrix dose in infants prior to primary pertussis vaccination when administ…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women [Phase 4]
Phase 4 trial assessing immunogenicity and safety of Boostrix vaccine in pregnant women has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary [NA]
A completed clinical trial study assessing the seroprevalence of Bordetella pertussis in adults in Hungary; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m [Phase 3]
Phase 3 trial update of Tritanrix-HepB/Hib-MenAC and Mencevax ACWY vaccines with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]
Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results pos…
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults [Phase 3]
Phase 3 results show immunogenicity and safety of GlaxoSmithKline's Boostrix Tdap vaccine in previously boosted young adults.
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose [Phase 4]
Phase 4 trial assessing safety and immunogenicity of Adacel booster given 10 years after prior dose in adults.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old [Phase 3]
Phase 3 trial assessing safety and immunogenicity of concomitant vs non-concomitant administration of REPEVAX and VAXIGRIP in adults aged 60…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older [Phase 3]
Phase 3 safety and immunogenicity update of REPEVAX followed by REVAXIS in adults 40+ years.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib [Phase 3]
Phase 3 trial shows non-inferiority of GSK's DTPw-HBV/Hib vaccine compared to two alternative formulations.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults [Phase 4]
Phase 4 trial reporting immunogenicity and safety of a booster dose of Boostrix Polio vaccine in adults previously boosted, with results pos…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine [Phase 4]
This Phase 4 clinical trial update reports safety and immunogenicity results of a booster dose of GSK's Boostrix-Polio vaccine; results were…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety (reactogenicity) of a booster dose of GSK's DTPa-HBV-IPV/Hib vaccine, with results po…
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: EUpertstrain 4 Study of Bordetella Pertussis Isolates
The EUpertstrain 4 study investigating Bordetella pertussis isolates has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately [Phase 3]
Phase 3 trial compares the immunogenicity and reactogenicity of the hexavalent vaccine DTPa-HBV-IPV/Hib with the separate DTPa-HBV-IPV and H…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly [Phase 2]
Phase 2 study assessing immunogenicity and safety of DTPa-HBV-IPV/Hib versus DTPa-IPV/Hib with concomitant hepatitis B administration, compl…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths [Phase 2]
Phase 2 trial evaluating immune response and safety of a DTPw-HBV/Hib booster vaccine given at 15-18 months; study completed.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age [Phase 3]
Phase 3 study evaluating immunogenicity, safety, and tolerability of a fully liquid pentavalent vaccine (DTwP-Hib-HepB) in infants aged 6-8 …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: The PertADO Geneva Trial [Phase 2]
A Phase 2 trial named the PertADO Geneva Trial for Pertussis has completed.